3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
20
Lymphoma, Non-Hodgkin
20
Leukemia, Myeloid, Acute
11
Hodgkin Disease
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Myelodysplastic Syndromes
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Lymphoma, Mantle-Cell
3
Lymphoma, Follicular
3
Gliosarcoma
3
Glioblastoma
3
Sezary Syndrome
2
Mycosis Fungoides
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Large-Cell, Immunoblastic
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, B-Cell, Marginal Zone
2
Lymphoma
2
Leukemia, Hairy Cell
2
Leukemia
2
Hematologic Neoplasms
2
Glioma
2
Burkitt Lymphoma
2
Warts
1
Waldenstrom Macroglobulinemia
1
Sarcoma, Myeloid
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Pinealoma
1
Interventions
Cisplatin
75
Cetuximab
63
Radiotherapy
38
pembrolizumab
29
Radiotherapy, Intensity-Modulated
28
Carboplatin
25
Fluorouracil
24
Docetaxel
24
Paclitaxel
19
Erlotinib Hydrochloride
13
Nivolumab
12
Radiation
10
Pemetrexed
10
durvalumab
8
Gemcitabine
8
Drug Therapy
8
Bevacizumab
7
zalutumumab
6
Surgical Procedures, Operative
6
Panitumumab
6
Lapatinib
6
Everolimus
6
Albumin-Bound Paclitaxel
6
130-nm albumin-bound paclitaxel
6
epacadostat
5
Standard of Care
5
Oxaliplatin
5
Gefitinib
5
Afatinib
5
Radiosurgery
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Head and Neck Neoplasms
×
plerixafor
×
Clear all
No trials found.